NCCN-Lilly RFP on quality of care in gastric cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The National Comprehensive Cancer Network announced a collaboration with Eli Lilly and Co. to offer a new opportunity seeking proposals to bridge gaps in care for gastric and gastroesophageal junction cancer patients in the U.S. The Request for Proposals outlines the scope and process that will be followed for the submission of Letters of Intent.

The intent of the RFP is to encourage U.S. organizations to submit LOIs describing concepts and ideas for developing, implementing, and evaluating programs that close clinical practice gaps and improve the quality of care for patients with gastric/GEJ cancer through adherence to evidence-based medicine guidelines, and improved competence and performance of health care providers and health care systems.

NCCN views this collaboration with Lilly as clear recognition of the advantages offered to industry and organizations treating cancer patients through the NCCN Oncology Research Program.

LOIs are due by 11:59 PM EDT, Wednesday, Oct. 24. Please direct questions in writing to Nicole Kamienski at with the subject line, “2018 Gastric Project.”


President Joe Biden’s proposed Advanced Research Projects Agency-Health would be a welcome partner to NCI—particularly in conducting large, collaborative clinical investigations, NCI Director Ned Sharpless said.“I think having ARPA-H as part of the NIH is good for the NCI,” Sharpless said April 11 in his remarks at the annual meeting of the American Association for Cancer Research. “How this would fit with the ongoing efforts in cancer at the NCI is still something to work out.”